BioHealth News Archive
Gliknik Enters Into Licensing Agreement With Pfizer for Drug Candidate Targeting Autoimmune Diseases
GL-2045 is Gliknik’s Lead Recombinant Stradomer™ Designed to Improve on Pooled Human Intravenous Immunoglobulin Gliknik Inc., a privately held biopharmaceutical company, today announced that…
Read More
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww?
Bureaucracy is one of the dirty words in business. Nobody wants to publicly admit their company is bogged down with too many layers of…
Read More
Here’s a look at healthcare’s top 10 corporate investors and acquirers
These days, having a strategic investor or partner has become almost a matter of survival for healthcare startups. Corporate investing and partnering has really…
Read More
Northrop Grumman, bwtech@UMBC Graduate First Three Companies From Cyber Cync Program NYSE:NOC
Northrop Grumman Corporation (NYSE:NOC) and the University of Maryland, Baltimore County's Research Park Corporation - also known as bwtech@UMBC - hosted a ceremony today…
Read More
Baltimore-based Gliknik enters into licensing agreement with Pfizer
BALTIMORE, MARYLAND, September 30, 2013 – Gliknik Inc., a privately held biopharmaceutical company, today announced that it has entered into an exclusive worldwide licensing…
Read More
New Investment Fund Will Advance Late-Stage Vaccines and other Global Health Technologies
A new investment fund structured by JPMorgan Chase & Co. (NYSE:JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow…
Read More
Jumpstart Our Business Startups (JOBS) Act: Impact on the Biotechnology Industry | BIO
President Obama signed the Jumpstart Our Business Startups (JOBS) Act into law on April 5, 2012. BIO advocated strongly for this new law, which…
Read More
Baltimore needs to shed old-fashioned ways to spark innovation – Baltimore Business Journal
Newt Fowler looked across Baltimore’s Renaissance Hotel ballroom and noted who was missing from the tables. Sure, there are plenty of leaders in today’s…
Read More
Maryland’s innovation economy has a lot in its favor — but more needs to be done – Baltimore Business Journal
What we’ve got in our corner: Everything from good schools to a really funky music scene. What we need to do: Everything from reform…
Read More
Sage Growth Partners sees business boom from electronic health record push – Baltimore Business Journal
Baltimore’s Sage Growth Partners sees opportunity where others see a headache. Over the past few years Sage, a health care technology consulting firm, has…
Read More
NCSES Business R&D Performance in the United States Increased in 2011 – US National Science Foundation (NSF)
Companies spent $294 billion on research and development performed in the United States during 2011, compared with $279 billion during 2010 (table 1). Funding…
Read MoreNIH announces awards to strengthen the biomedical research workforce
The National Institutes of Health is making available approximately $3.7 million for awards to enhance training opportunities for graduate students and postdoctoral scholars to…
Read More
University of Maryland entrepreneurship program extends eligibility to all majors
Anyone can have a great business idea, and now students don't have to be enrolled in the business school to get help making their…
Read More
MedImmune, University of Maryland, Baltimore team on research – Baltimore Business Journal
University of Maryland, Baltimore and MedImmune are pairing up for a five-year, $6 million collaboration on bioscience research. The Gaithersburg-based drug company and the…
Read More
GSK, Merck and Pfizer join JP Morgan vaccine investment fund – FierceVaccines
The success of MenAfriVac shows vaccines can be developed outside Big Pharma's walls, but, in most cases, the cost of late-phase trials is too…
Read More